Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Net Sales
875.17
172.17
0.00
0.00
0.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
Total Operating income
875.17
172.17
0.00
0.00
0.00
Raw Material Cost
135.18
107.63
35.67
35.51
30.91
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
Employee Cost
165.61
183.01
245.75
136.39
86.02
Power Cost
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
24.03
25.36
18.59
21.74
310.85
Selling and Distribution Expenses
117.67
108.75
172.56
81.97
52.67
Other Expenses
7.67
13.66
11.20
11.26
-23.86
Total Expenditure (Excl Depreciation)
519.19
561.33
584.54
388.19
241.87
Operating Profit (PBDIT) excl Other Income
356
-389.20000000000005
-584.5
-388.2
-241.9
Other Income
-0.86
30.71
20.75
32.83
30.84
Operating Profit (PBDIT)
389.92
-323.03
-528.11
-319.84
-180.13
Interest
24.03
25.36
18.59
21.74
310.85
Exceptional Items
2.27
4.59
6.30
13.83
7.81
Gross Profit (PBDT)
739.99
64.54
-35.67
-35.51
-30.91
Depreciation
34.81
35.42
35.67
35.51
30.91
Profit Before Tax
333.35
-379.22
-576.07
-363.26
-514.08
Tax
-0.08
-0.08
-0.08
-0.08
-0.09
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
Profit After Tax
341.03
-363.84
-561.06
-346.76
-359.48
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
Net Profit
341.03
-363.84
-561.06
-346.76
-359.48
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
Minority Interest
-7.60
-15.30
-14.93
-16.42
-18.60
Other related items
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
333.43
-379.14
-575.99
-363.18
-378.08
Equity Capital
0.00
0.00
0.00
0.00
0.00
Face Value
1.11
1.06
1.1
1.12
1.22
Reserves
773.02
243.68
324.54
720.48
820.02
Earnings per share (EPS)
1.52
-1.66
-2.53
-1.56
-1.62
Diluted Earnings per share
1.52
-1.66
-2.53
-1.56
-1.62
Operating Profit Margin (Excl OI)
40.68%
-226.04%
0.0%
0.0%
0.0%
Gross Profit Margin
42.07%
-199.69%
0.0%
0.0%
0.0%
PAT Margin
38.97%
-211.33%
0.0%
0.0%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 408.25% vs 0.00% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 187.95% vs 34.18% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 210.49% vs 35.56% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -5.51% vs 36.56% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Qyuns Therapeutics Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(HKD)
Change(%)
Net Sales
875.17
0
875.17
Other Operating Income
0.00
0.00
0.00
Total Operating income
875.17
0
875.17
Raw Material Cost
135.18
0
135.18
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
165.61
0
165.61
Power Cost
0
0
0.00
Manufacturing Expenses
24.03
0
24.03
Selling and Distribution Expenses
117.67
0
117.67
Other Expenses
7.67
0.00
7.67
Total Expenditure (Excl Depreciation)
519.19
0
519.19
Operating Profit (PBDIT) excl Other Income
355.98
0.00
355.98
Other Income
-0.86
0
-0.86
Operating Profit (PBDIT)
389.92
0
389.92
Interest
24.03
0
24.03
Exceptional Items
2.27
0
2.27
Gross Profit (PBDT)
739.99
0
739.99
Depreciation
34.81
0
34.81
Profit Before Tax
333.35
0
333.35
Tax
-0.08
0
-0.08
Provisions and contingencies
0
0
0.00
Profit After Tax
341.03
0
341.03
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
341.03
0
341.03
Share in Profit of Associates
0
0
0.00
Minority Interest
-7.60
0
-7.60
Other related items
0.00
0.00
0.00
Consolidated Net Profit
333.43
0
333.43
Equity Capital
0
0
0.00
Face Value
1.11
0
0.00
Reserves
773.02
0
773.02
Earnings per share (EPS)
1.52
0
1.52
Diluted Earnings per share
1.52
0
1.52
Operating Profit Margin (Excl OI)
40.68%
0%
0.00
40.68%
Gross Profit Margin
42.07%
0%
0.00
42.07%
PAT Margin
38.97%
0%
0.00
38.97%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 87.52 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 408.25% vs 0.00% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 33.34 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 187.95% vs 34.18% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 39.08 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 210.49% vs 35.56% in Dec 2024
Annual - Interest
Interest 2.40 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -5.51% vs 36.56% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 40.68%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






